Estimated Impact of Long-Acting Injectable PrEP in South Africa: A Model Comparison Analysis

This CME activity is part of a collection of articles and questions aimed to enhance the learner's understanding of the evolving HIV prevention landscape by examining evidence from real-world data, implementation strategies, user preferences and health system implications related to expanding access to and choice of PrEP modalities across diverse populations and settings.

Target Audience

Healthcare Professionals

Learning Objectives

  • Describe the current HIV prevention landscape, including the PrEP options now available (oral, injectable and other long-acting forms).
  • Evaluate real-world evidence on how well people use, stay on and benefit from different PrEP options across diverse populations.
  • Identify implementation strategies that expand access to PrEP and the choice between options in different healthcare settings.
  • Recognise user preferences and barriers that affect whether people take up and stay on each PrEP option.
  • Assess what offering multiple PrEP options means for health systems, including resources, delivery models and equity.
  • Apply this evidence to support person-centred PrEP choices in clinical practice.

Activity Disclosure

No commercial support has been accepted related to the development or publication of this activity.

Course summary

Available credit: 
  • 1.00 AMA PRA Category 1 Credit(s)™
Course opens: 
07/02/2025
Course expires: 
07/01/2028
Cost:
$0.00
Rating: 
0

Article Authours

Sarah E. Stansfield, Mia Moore, Lise Jamieson, Gesine Meyer-Rath, Leigh F. Johnson, David Kaftan, Anna Bershteyn, Jennifer Smith, Valentina Cambiano, Loveleen Bansi-Matharu, Andrew Phillips, Jesse Heitner, Ruanne V. Barnabas, Brett Hanscom, Deborah J. Donnell, Marie-Claude Boily, Dobromir Dimitrov

CME Editor

 

Sarah Stansfield

Sarah Stansfield

Sarah Stansfield has nothing to disclose.

John Wiley & Sons, Inc. is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

John Wiley and Sons, Inc. designates this journal-based CME activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity. For information on applicability and acceptance of continuing medical education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within 1 hour. To successfully earn credit, participants must complete the activity during the valid credit period, which is up to three years from initial publication. Additionally, up to 3 attempts and a score of 80% or better is needed to pass the post test and claim CC credit. [ACGME competency/CC category: Medical Knowledge].

Available Credit

  • 1.00 AMA PRA Category 1 Credit(s)™

Price

Cost:
$0.00
Please login or register to take this course.